Focus:
Pancreatic cancer is considered to be one of the most aggressive solid tumours; despite low incidence, it remains the fourth…
Read More…
US President Donald Trump has signed an executive order that requires the federal government to...
Read More...
Treatment of diffuse large B-cell lymphoma (DLBCL), the most common type of B-cell non-Hodgkin’s lymphoma, had seen a major transformation…
Read More…
Biogen has entered into a binding agreement with Denali Therapeutics to jointly develop and commercialise...
Read More...
The US Department of Justice is seeking approximately $13bn in criminal and civil penalties from...
Read More...
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline (GSK)'s Blenrep (belantamab mafodotin-blmf) as...
Read More...
Johnson & Johnson unit Janssen Pharmaceutical has signed an agreement with the US Government for...
Read More...
Micronova designs and manufactures wipers, soaps and mop systems for aseptic processing, pharmaceutical production and...
Read More...
Israel-based Teva Pharmaceutical has formed an exclusive strategic collaboration with Alvotech to commercialise five biosimilar...
Read More...
Solid tumour personalised immunotherapy company Imvax has raised $112m in a Series C funding round....
Read More...
